PCK 0.00% 2.7¢ painchek ltd

Studies by RAP have a weak efficacy for a medial diagnostic...

  1. 330 Posts.
    lightbulb Created with Sketch. 57
    Studies by RAP have a weak efficacy for a medial diagnostic tool. The associated liability with a misdiagnosis is far too high. Neither the patient or the physician will truly trust the app. I had a clinical specialist review RAP's clinical trail results - his response was 'meh'. No hard evidence and a bit of pseudo science saying that you can diagnose something from the sound of a cough.

    Good luck.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.000(0.00%)
Mkt cap ! $44.16M
Open High Low Value Volume
2.7¢ 2.7¢ 2.7¢ $4.09K 151.4K

Buyers (Bids)

No. Vol. Price($)
3 785540 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 517995 4
View Market Depth
Last trade - 12.34pm 25/06/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.